Virginia A Triant1,2, Ellie Grossman3, Nancy A Rigotti1, Rekha Ramachandran4, Susan Regan1, Scott E Sherman5,6, Kimber P Richter7, Hilary A Tindle8, Kathleen F Harrington9. 1. Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA. 2. Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA. 3. Cambridge Health Alliance, Somerville, MA. 4. Division of Preventive Medicine, School of Medicine, University of Alabama, Birmingham, AL. 5. Department of Population Health, New York University School of Medicine, New York, NY. 6. VA New York Harbor Healthcare System, New York, NY. 7. Department of Preventive Medicine and Public Health, University of Kansas Medical Center, Kansas City, Kansas, Nashville, TN. 8. Division of General Internal Medicine and Public Health, Vanderbilt University School of Medicine, Nashville, TN. 9. Division of Pulmonary, Allergy and Critical Care Medicine, School of Medicine, University of Alabama, Birmingham, AL.
Abstract
INTRODUCTION: Smoking is a key determinant of mortality among people living with HIV (PLWH). METHODS: To better understand the effects of smoking cessation interventions in PLWH, we conducted a pooled analysis of four randomized controlled trials of hospital-initiated smoking interventions conducted through the Consortium of Hospitals Advancing Research on Tobacco (CHART). In each study, cigarette smokers were randomly assigned to usual care or a smoking cessation intervention. The primary outcome was self-reported past 30-day tobacco abstinence at 6-month follow-up. Abstinence rates were compared between PLWH and participants without HIV and by treatment arm, using both complete-case and intention-to-treat analyses. Multivariable logistic regression was used to determine the effect of HIV status on 6-month tobacco abstinence and to determine predictors of smoking cessation within PLWH. RESULTS: Among 5550 hospitalized smokers, there were 202 (3.6%) PLWH. PLWH smoked fewer cigarettes per day and were less likely to be planning to quit than smokers without HIV. At 6 months, cessation rates did not differ between intervention and control groups among PLWH (28.9% vs. 30.5%) or smokers without HIV (36.1% vs. 34.1%). In multivariable regression analysis, HIV status was not significantly associated with smoking cessation at 6 months. Among PLWH, confidence in quitting was the only clinical factor independently associated with smoking cessation (OR 2.0, 95% CI = 1.4 to 2.8, p < .01). CONCLUSIONS: HIV status did not alter likelihood of quitting smoking after hospital discharge, whether or not the smoker was offered a tobacco cessation intervention, but power was limited to identify potentially important differences. IMPLICATIONS: PLWH had similar quit rates to participants without HIV following a hospital-initiated smoking cessation intervention. The findings suggest that factors specific to HIV infection may not influence response to smoking cessation interventions and that all PLWH would benefit from efforts to assist in quitting smoking. TRIAL REGISTRATION: (1) Using "warm handoffs" to link hospitalized smokers with tobacco treatment after discharge: study protocol of a randomized controlled trial: NCT01305928. (2) Web-based smoking cessation intervention that transitions from inpatient to outpatient: NCT01277250. (3) Effectiveness of smoking-cessation interventions for urban hospital patients: NCT01363245. (4) Effectiveness of Post-Discharge Strategies for Hospitalized Smokers (HelpingHAND2): NCT01714323.
RCT Entities:
INTRODUCTION: Smoking is a key determinant of mortality among people living with HIV (PLWH). METHODS: To better understand the effects of smoking cessation interventions in PLWH, we conducted a pooled analysis of four randomized controlled trials of hospital-initiated smoking interventions conducted through the Consortium of Hospitals Advancing Research on Tobacco (CHART). In each study, cigarette smokers were randomly assigned to usual care or a smoking cessation intervention. The primary outcome was self-reported past 30-day tobacco abstinence at 6-month follow-up. Abstinence rates were compared between PLWH and participants without HIV and by treatment arm, using both complete-case and intention-to-treat analyses. Multivariable logistic regression was used to determine the effect of HIV status on 6-month tobacco abstinence and to determine predictors of smoking cessation within PLWH. RESULTS: Among 5550 hospitalized smokers, there were 202 (3.6%) PLWH. PLWH smoked fewer cigarettes per day and were less likely to be planning to quit than smokers without HIV. At 6 months, cessation rates did not differ between intervention and control groups among PLWH (28.9% vs. 30.5%) or smokers without HIV (36.1% vs. 34.1%). In multivariable regression analysis, HIV status was not significantly associated with smoking cessation at 6 months. Among PLWH, confidence in quitting was the only clinical factor independently associated with smoking cessation (OR 2.0, 95% CI = 1.4 to 2.8, p < .01). CONCLUSIONS:HIV status did not alter likelihood of quitting smoking after hospital discharge, whether or not the smoker was offered a tobacco cessation intervention, but power was limited to identify potentially important differences. IMPLICATIONS: PLWH had similar quit rates to participants without HIV following a hospital-initiated smoking cessation intervention. The findings suggest that factors specific to HIV infection may not influence response to smoking cessation interventions and that all PLWH would benefit from efforts to assist in quitting smoking. TRIAL REGISTRATION: (1) Using "warm handoffs" to link hospitalized smokers with tobacco treatment after discharge: study protocol of a randomized controlled trial: NCT01305928. (2) Web-based smoking cessation intervention that transitions from inpatient to outpatient: NCT01277250. (3) Effectiveness of smoking-cessation interventions for urban hospital patients: NCT01363245. (4) Effectiveness of Post-Discharge Strategies for Hospitalized Smokers (HelpingHAND2): NCT01714323.
Authors: Jack E Burkhalter; Carolyn M Springer; Rosy Chhabra; Jamie S Ostroff; Bruce D Rapkin Journal: Nicotine Tob Res Date: 2005-08 Impact factor: 4.244
Authors: Krishna P Reddy; Robert A Parker; Elena Losina; Travis P Baggett; A David Paltiel; Nancy A Rigotti; Milton C Weinstein; Kenneth A Freedberg; Rochelle P Walensky Journal: J Infect Dis Date: 2016-11-03 Impact factor: 5.226
Authors: Rennatus Mdodo; Emma L Frazier; Shanta R Dube; Christine L Mattson; Madeline Y Sutton; John T Brooks; Jacek Skarbinski Journal: Ann Intern Med Date: 2015-03-03 Impact factor: 25.391
Authors: K Petoumenos; S Worm; P Reiss; S de Wit; A d'Arminio Monforte; C Sabin; N Friis-Møller; R Weber; P Mercie; C Pradier; W El-Sadr; O Kirk; J Lundgren; Mg Law Journal: HIV Med Date: 2011-01-20 Impact factor: 3.180
Authors: Shahida Shahrir; Hilary A Tindle; Kathleen A McGinnis; David A Fiellin; Joseph Goulet; Kathleen M Akgün; Cynthia L Gibert; Maria C Rodriguez-Barradas; Kristina Crothers Journal: Subst Abus Date: 2015-07-13 Impact factor: 3.716
Authors: J Schäfer; J Young; E Bernasconi; B Ledergerber; D Nicca; A Calmy; M Cavassini; H Furrer; M Battegay; Hc Bucher Journal: HIV Med Date: 2014-05-08 Impact factor: 3.180
Authors: Kathleen F Harrington; Julie A McDougal; Maria Pisu; Bin Zhang; Rajani S Sadasivam; Thomas K Houston; William C Bailey Journal: Trials Date: 2012-08-01 Impact factor: 2.279